Abstract
DASFREE: Treatment-Free Remission (TFR) After Discontinuation of Dasatinib in Patients with Chronic Myeloid Leukemia in Chronic Phase (CML-CP) and Deep Molecular Response (DMR)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have